David Fowler Selected Research

Paranoid Disorders (Paranoia)

7/2022	Bridging the Digital Divide in Psychological Therapies: Observational Study of Engagement With the SlowMo Mobile App for Paranoia in Psychosis.
1/2022	SlowMo therapy, a new digital blended therapy for fear of harm from others: An account of therapy personalisation within a targeted intervention.
1/2022	The service user experience of SlowMo therapy: A co-produced thematic analysis of service users' subjective experience.
1/2021	Effects of SlowMo, a Blended Digital Therapy Targeting Reasoning, on Paranoia Among People With Psychosis: A Randomized Clinical Trial.
12/2018	Persecutory delusions: effects of Cognitive Bias Modification for Interpretation and the Maudsley Review Training Programme on social anxiety, jumping to conclusions, belief inflexibility and paranoia.
11/2017	SlowMo, a digital therapy targeting reasoning in paranoia, versus treatment as usual in the treatment of people who fear harm from others: study protocol for a randomised controlled trial.
10/2017	The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysis.
5/2005	The psychology of persecutory ideation II: a virtual reality experimental study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Fowler Research Topics

Disease

42	Psychotic Disorders (Schizoaffective Disorder) 07/2022 - 04/2003
8	Paranoid Disorders (Paranoia) 07/2022 - 05/2005
6	Mental Disorders (Mental Disorder) 01/2022 - 11/2017
4	Schizophrenia (Dementia Praecox) 01/2022 - 04/2003
4	Thrombosis (Thrombus) 01/2021 - 05/2002
3	Wounds and Injuries (Trauma) 05/2022 - 07/2006
3	Rupture 12/2016 - 02/2010
3	Sudden Death 09/2013 - 05/2010
2	Substance-Related Disorders (Drug Abuse) 05/2022 - 05/2016
2	Anxiety Disorders (Anxiety Disorder) 03/2016 - 07/2013
2	Asperger Syndrome (Asperger's Syndrome) 03/2016 - 07/2013
2	Hypersensitivity (Allergy) 01/2015 - 04/2009
2	Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy) 01/2013 - 01/2012
2	Atherosclerotic Plaque (Atheroma) 01/2011 - 02/2010
2	Pain (Aches) 08/2003 - 07/2003
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 05/2022
1	Death (Near-Death Experience) 03/2022
1	Drug Overdose 01/2022
1	Treatment-Resistant Schizophrenia 09/2020
1	Alzheimer Disease (Alzheimer's Disease) 11/2018
1	Amyloid Plaque 11/2018
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2018
1	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2017
1	Hallucinations (Hallucination) 10/2017
1	Myocarditis (Carditis) 03/2017
1	Surgical Wound Infection 10/2015
1	Cardiomyopathies (Cardiomyopathy) 01/2013
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2013
1	Epilepsy (Aura) 11/2012
1	Coronary Disease (Coronary Heart Disease) 10/2012
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2011
1	Spinal Cord Injuries (Spinal Cord Injury) 06/2010
1	Inflammation (Inflammations) 05/2010
1	Pathologic Constriction (Stenosis) 05/2010
1	Bites and Stings (Sting) 04/2009
1	Anaphylaxis (Anaphylactic Shock) 04/2009
1	Cardiac Arrhythmias (Arrythmia) 10/2007
1	Multiple Sclerosis 09/2005
1	Sudden Infant Death (SID) 03/2005
1	Asphyxia (Suffocation) 03/2005
1	Chronic Pain 09/2003
1	Arthritis (Polyarthritis) 09/2003
1	Neoplasms (Cancer) 09/2003
1	Body Weight (Weight, Body) 07/2003
1	Ascites 05/2002
1	Lethargy 05/2002
1	Urethral Obstruction 04/2002

Drug/Important Bio-Agent (IBA)

16	Polytetrafluoroethylene (Teflon)FDA Link 11/2021 - 01/2013
4	Phenobarbital (Luminal)FDA Link 01/2021 - 02/2010
4	O(6)-codeine methyl ether (OCME)IBA 03/2017 - 03/2005
3	ProdigyIBA 01/2022 - 11/2017
3	Antipsychotic Agents (Antipsychotics)IBA 09/2020 - 07/2019
2	CollagenIBA 01/2021 - 12/2016
2	LipidsIBA 01/2018 - 01/2011
2	Proteins (Proteins, Gene)FDA Link 01/2013 - 01/2012
2	Meloxicam (Mobic)FDA LinkGeneric 08/2003 - 07/2003
1	SootIBA 03/2022
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2022
1	Clozapine (Clozaril)FDA LinkGeneric 09/2020
1	Opioid Analgesics (Opioids)IBA 04/2019
1	metariboadenosine triphosphorousIBA 12/2018
1	Apolipoproteins E (ApoE)IBA 11/2018
1	Apolipoprotein E4IBA 11/2018
1	Dihydrotachysterol (AT 10)IBA 10/2017
1	Proteoglycans (Proteoglycan)IBA 12/2016
1	Pharmaceutical PreparationsIBA 12/2013
1	Thyroid HormonesIBA 09/2013
1	Cadherins (E-Cadherin)IBA 01/2013
1	gamma Catenin (Plakoglobin)IBA 01/2013
1	PlakophilinsIBA 01/2013
1	Desmoplakins (Desmoplakin)IBA 01/2013
1	Ion Channels (Ion Channel)IBA 01/2012
1	CholesterolIBA 01/2011
1	P-2 (P 2)IBA 05/2010
1	3' Untranslated Regions (3' UTR)IBA 05/2010
1	chemotactic factor inactivatorIBA 04/2010
1	Hair DyesIBA 04/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2009
1	AllergensIBA 04/2009
1	Sevoflurane (Ultane)FDA LinkGeneric 10/2007
1	Indicators and Reagents (Reagents)IBA 11/2006
1	Biological ProductsIBA 10/2006
1	N 30IBA 05/2005
1	Delayed-Action PreparationsIBA 09/2003
1	Oxycodone (Oxycontin)FDA LinkGeneric 09/2003
1	AcepromazineIBA 07/2003
1	Butorphanol (BC 2627)FDA LinkGeneric 07/2003

Therapy/Procedure

33	Therapeutics 07/2022 - 04/2003
2	Treatment Delay 01/2020 - 07/2013
1	Pain Management 04/2019
1	Stents 01/2018
1	Osteotomy 10/2015
1	Drug-Eluting Stents 01/2015
1	Secondary Prevention 10/2007
1	Patient Readmission 11/2006
1	Surgical Amputation (Amputations) 07/2006
1	Infant Equipment (Crib) 03/2005
1	Anesthesia 08/2003
1	Laparotomy 05/2002
1	Ligation 04/2002